The exquisitely exacting and expensive process (three to four times more costly than reliable black and white) was a major ...

"This is a historic moment for 4DMT as we become a Phase 3 company following our initiation of the 4FRONT-1 clinical trial,” said David Kirn, M.D., Co-founder and Chief Executive Officer of 4DMT.

D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted ...

Canon Medical proudly announces that major AI enhancements have been cleared for the Aquilion ONE / INSIGHT Edition - including the new PIQE 1024 matrix and SilverBeam across a broader range of ...

Leonardo DRS, Inc. (NASDAQ: DRS) announced today that its cutting-edge Stretto® semiconductor laser technology has been honored with the prestigious SPIE Prism Award for its exceptional innovation in ...

NTT Research, Inc., a division of NTT (TYO:9432), today announced plans to hold Upgrade 2025, NTT’s Global Research & ...

But some important themes that contributed to its incredible growth include a combination of continuous innovation, strategic and at times ruthless management, strong brand loyalty, and a robust ...

Only 26% of companies have developed working AI products, and only 4% have achieved significant returns on their investments, according to 2024 study. Bridging the gap between aspiration and ...

ABBOTT PRISM increases throughput by running up to 160 samples per hour with STAT test capability in under one hour. ABBOTT PRISM increases throughput while reducing the number of failed runs due ...